Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 18:03 (UTC)
Created April 17, 2026, 18:03 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-03-23 00:00:00
open_canada_keywords {"fr": ["pandémie de COVID-19", "drogues destinées aux essais cliniques sur des sujets humains", "comités d’éthique de la recherche."], "en": ["COVID-19 pandemic", "drugs for clinical trials involving human subjects", "Research Ethics Board (REB)."]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques
update_frequency as_needed